OUR LEADERSHIP
WHERE THE PASSION BEGINS
We are comprised of first-rate consultants with strong networks in both developed and emerging pharmaceutical markets. Using our expertise in both science and business, our team is dedicated to ensuring the highest quality of service for you and your team.
JIANWEI XU, PHD
Jianwei is experienced in strategy, competitive intelligence, M&A, licensing, and partnership. Prior to establishing Cambridge Solutions, he was an associate at McKinsey & Company where he worked with middle and upper management of major pharmaceutical companies on planning and implementing strategies for achieving a superior competitive position for the clients and delivering tremendous value to the clients. Jianwei also worked as a project manager for Business Research Group where he managed multinational teams to serve the strategic intelligence needs of pharmaceutical clients
​
He has published in prestigious scientific journals such as Science and Nature Reviews Neuroscience. He conducted three years of postdoctoral research in neurological diseases at the University of Pennsylvania and the Children's Hospital of Philadelphia
​
Jianwei has obtained and maintained multiple 'Top 10' pharmaceutical clients since establishing Cambridge Solutions in 2010 by upholding the highest standard of work as the Director of a first-rate team of consultants, business analysts & project managers
LOTTE WANG, PHD
Lotte has accrued diverse pharmaceutical industry experience, spanning from drug discovery, clinical development, strategic planning to licensing/business development, during her tenure of 26 years with Bristol-Myers Squibb Co. As a Licensing Director, she led numerous technical due diligences and played key roles in worldwide deals with biotech and major pharmaceutical companies. In addition to strategic planning, she implemented an in-house competitive intelligence network, conducted decision analyses and portfolio management of pipeline projects and marketed products. She gained substantial drug development and life-cycle management skills as a project manager, including a major, successful global regulatory filing
​
Earlier in her career, she conducted research in cancer discovery and performed drug metabolism & PK studies. Her experience covers oncology, cardiovascular/metabolic, antiviral, immunology and dermatology
​
Lotte received her Pharmacy degree, M.S in Biochemistry & Ph. D. in Molecular Biology from the University of Sao Paulo, Brazil
KEVIN KREBS, MS
Prior to joining Cambridge Solutions, Kevin conducted 3 years of oncology research at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL. During this time, he designed and executed a novel study investigating the role of angiogenesis gene SNPs in melanoma outcomes, which was published in Cancer Epidemiology, Biomarkers & Prevention
​
More recently, Kevin performed oligonucleotide synthesis and manipulation as a Research Associate at Stratos Genomics, a Biotech start-up in Seattle, WA developing a novel DNA-sequencing platform
​
At Cambridge Solutions, his areas of focus include CNS, oncology and virology, and he is especially passionate about conference coverage & primary research
​
He received both his B.S.E. in ChemE and Masters in Biotechnology from University of Pennsylvania
GRANT ZENG, MBA, MS, CFA
Grant has more than 20 years of medical research, M&A and investment banking experience. Before joining Cambridge Solutions, he was a senior security analyst at Zacks Investment Research, responsible for the analysis of U.S. listed pharmaceutical and biotechnology companies
​
Prior to joining Zacks, Grant worked as a senior security analyst at TheStreet.com, responsible for the pharmaceutical and biotech industries; at China Pacific Insurance Company, he served as senior analyst, responsible for the analysis of fund companies and listed companies; as an analyst at U.S. investment bank Young & Partners, he was responsible for M&A research
​
He obtained his Masters degree in business administration from McMaster University, majoring in finance and accounting. He obtained his Masters in biochemistry from University of Western Ontario and a Master's degree in Pharmacology from Second Military Medical University in Shanghai
​
Grant is also a Chartered Financial Analyst with U.S. securities industry qualifications
MAREK KONDRACIUK, MBA
Marek has over 20 years of experience in pharmaceutical industry. His main education background is in Bioethics and Pharmacoeconomics. He also obtained eMBA from Institute of Economics of the Polish Academy of Sciences
​
Prior to joining Cambridge Solutions, Marek was a sales manager in EGZOtech Ltd., where he achieved success in leading the team and developing market strategies in the pharma business, including building sales, budget & target execution, market access activities, as well as launching new products
​
He is familiar with the clinical trial process from Ph1 to Ph4. At Synexus Clinical Research Ltd., he was responsible for patient recruitment and retention in many clinical trials across a range of therapeutic areas, such as CNS, cardiology, nephrology, and diabetes/metabolic disease
​
Marek has a vast network of doctor, nurse, hospital administrator, patient & health care organization contacts in Europe
VIVIAN NGUYEN, BS
Vivian obtained her BS in Neuroscience from Colorado College. As an undergraduate research assistant, she traced and quantified 395 neurons from Golgi stains of the cheetah and African lion cortices and published her findings as first author in The Journal of Comparative Neurology
​
She has also worked as a laboratory technician for Rush University’s Department of Microbial Pathogens and Immunity researching the neurophysiology of drugs of abuse, HIV/AIDS, and Alzheimer's Disease (AD)
​
Since joining Cambridge Solutions, Vivian has contributed to successful CI projects in MS, RSV, and Mood Disorders, with particular expertise in conducting primary research, including KOL interviews
